Jan Komtebedde
Direttore Tecnico/Scientifico/R&S presso Corvia Medical, Inc.
Profilo
Jan Komtebedde is currently the Chief Medical Officer & Senior Vice President at Corvia Medical, Inc. He previously worked as the Director-Structural Heart Business Unit at Abbott Laboratories, Director-Clinical Research & Development at Heartport, Inc., Chief Medical Officer & Executive Vice President at Ancora Heart, Inc., Vice President-Marketing & Business Development at Evalve, Inc., and as a Faculty Member at UC Davis School of Medicine.
He holds a doctorate degree from the University of Utrecht.
Posizioni attive di Jan Komtebedde
Società | Posizione | Inizio |
---|---|---|
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jan Komtebedde
Società | Posizione | Fine |
---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Direttore Tecnico/Scientifico/R&S | - |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Direttore Tecnico/Scientifico/R&S | - |
UC Davis School of Medicine | Corporate Officer/Principal | - |
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Vendite & Marketing | - |
Formazione di Jan Komtebedde
University of Utrecht | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ABBOTT LABORATORIES | Health Technology |
Aziende private | 4 |
---|---|
Evalve, Inc.
Evalve, Inc. Medical SpecialtiesHealth Technology Evalve, Inc. designs, develops, manufactures and markets devices. It developed a proprietary system which enables percutaneous repair of cardiac valves. The firm's products reduces the risks, trauma, and costs associated with current open, arrested heart surgical options. The company was founded on June 9, 1999 and is headquartered in Menlo Park, CA. | Health Technology |
Heartport, Inc.
Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Corvia Medical, Inc.
Corvia Medical, Inc. Medical SpecialtiesHealth Technology Corvia Medical, Inc. develops medical devices for the treatment of heart failure. It also offers transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction. The company was founded by David S. Celermajer and is headquartered in Tewksbury, MA. | Health Technology |
Ancora Heart, Inc.
Ancora Heart, Inc. Investment ManagersFinance Ancora Heart, Inc. manufactures medical devices for the treatment of mitral valve regurgitation. It develops percutaneous cardiac procedures for mitral valve regurgitation. The company was founded in 2001 by Lewis C. Pell, Niel F. Starksen and Nathan B. Pliam and is headquartered in Santa Clara, CA. | Finance |
- Borsa valori
- Insiders
- Jan Komtebedde